GLYC
GlycoMimetics Inc
NASDAQ: GLYC · HEALTHCARE · BIOTECHNOLOGY
$0.16
+0.00% today
Updated 2026-04-30
Market cap
$10.13M
P/E ratio
—
P/S ratio
1,095.16x
EPS (TTM)
$-46.00
Dividend yield
—
52W range
$0 – $18
Volume
—
GlycoMimetics Inc (GLYC) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-13.6%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+100.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-06-30 | $0.00 | $0.00 | — | — | — |
| 2025-03-31 | $-0.05 | $-0.04 | +20.0% | — | — |
| 2024-12-31 | $-0.09 | $-0.11 | -24.4% | $54086.00 | +440.9% |
| 2024-09-30 | $-0.11 | $-0.15 | -36.4% | — | — |
| 2024-06-30 | $-0.17 | $-0.16 | +5.9% | — | — |
| 2024-03-31 | $-0.16 | $-0.17 | -6.3% | — | — |
| 2023-12-31 | $-0.15 | $-0.14 | +6.7% | $10000.00 | +13233.3% |
| 2023-09-30 | $-0.14 | $-0.14 | +0.0% | — | — |
| 2023-06-30 | $-0.18 | $-0.13 | +27.8% | — | — |
| 2023-03-31 | $-0.17 | $-0.17 | +0.0% | — | — |
| 2022-12-31 | $-0.17 | $-0.19 | -11.8% | $75.00 | — |
| 2022-09-30 | $-0.26 | $-0.16 | +38.5% | — | — |
Frequently asked questions
Has GlycoMimetics Inc beaten earnings estimates?
GlycoMimetics Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -13.6% over the last 3 quarters.